Endotoxin contamination alters macrophage-cancer cell interaction and therapeutic efficacy in pre-clinical 3D in vitro models

被引:7
|
作者
Heinrich, Marcel Alexander [1 ]
Heinrich, Lena [1 ]
Ankone, Marc J. K. [1 ]
Vergauwen, Bjorn [2 ]
Prakash, Jai [1 ]
机构
[1] Univ Twente, Tech Med Ctr, Dept Adv Organ Bioengn & Therapeut, Engn Therapeut Sect, NL-7500 AE Enschede, Netherlands
[2] Rousselot bvba, Expertise Ctr, B-9000 Ghent, Belgium
来源
BIOMATERIALS ADVANCES | 2023年 / 144卷
关键词
Lipopolysaccharide; 3D bioprinting; Gelatin methacryloyl; Tumor -associated macrophages; Immunotherapy; TUMOR-ASSOCIATED MACROPHAGES; LIPOPOLYSACCHARIDE; GROWTH; BIOMATERIALS;
D O I
10.1016/j.bioadv.2022.213220
中图分类号
TB3 [工程材料学]; R318.08 [生物材料学];
学科分类号
0805 ; 080501 ; 080502 ;
摘要
The rapid developments in biofabrication, in particular 3D bioprinting, in the recent years have facilitated the need for novel biomaterials that aim to replicate the target tissue in great detail. The presence of endotoxins in these biomaterials is often an overlooked problem. In pre-clinical 3D in vitro models, endotoxins can have significant influence on cell behavior and credibility of the model. In this study we demonstrate the effects of high levels of endotoxins in commercially-available gelatin on the macrophage-cancer cell crosstalk in a 3D bioprinted co-culture model. First, it is demonstrated that, while presenting the same mechanical and structural stimuli, high levels of endotoxin can have significant influence on the metabolic activity of macrophages and cancer cells. Furthermore, this study shows that high endotoxin contamination causes a strong inflammatory reaction in macrophages and significantly inhibits the effects of a paracrine macrophage-cancer cell co-culture. At last, it is demonstrated that the differences in endotoxin levels can drastically alter the efficacy of novel macrophage modulating immunotherapies, AS1517499 and 3-methyladenine. Altogether, this study shows that endotoxin contamination in biomaterials can significantly alter intra- and intercellular communication and thereby drug efficacy, which might lead to misinterpretation of the potency and safety of the tested compounds.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology
    Olivia Candini
    Giulia Grisendi
    Elisabetta Manuela Foppiani
    Matteo Brogli
    Beatrice Aramini
    Valentina Masciale
    Carlotta Spano
    Tiziana Petrachi
    Elena Veronesi
    Pierfranco Conte
    Giorgio Mari
    Massimo Dominici
    Scientific Reports, 9
  • [22] Skin-Grafting and Dendritic Cell "Boosted" Humanized Mouse Models Allow the Pre-Clinical Evaluation of Therapeutic Cancer Vaccines
    Zeng, Bijun
    Moi, Davide
    Tolley, Lynn
    Molotkov, Natalie
    Frazer, Ian Hector
    Perry, Christopher
    Dolcetti, Riccardo
    Mazzieri, Roberta
    Cruz, Jazmina L. G.
    CELLS, 2023, 12 (16)
  • [23] Modelling MERRF in 3D cortical organoids: manipulating patientderived iPSCs to gain insight on prospective pre-clinical therapeutic strategies
    Capirossi, Giada
    Capristo, Mariantonietta
    Sacchetti, Giulia
    Del Dotto, Valentina
    Fiorini, Claudio
    Caporali, Leonardo
    La Morgia, Chiara
    Pisano, Annalinda
    Giordano, Carla
    D'Amati, Giulia
    Le, Stephanie
    Prigione, Alessandro
    Carelli, Valerio
    Maresca, Alessandra
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 2024, 1865 : 137 - 137
  • [24] Therapeutic efficacy of anti-MMP9 antibody in combination with nab-paclitaxel-based chemotherapy in pre-clinical models of pancreatic cancer
    Awasthi, Niranjan
    Mikels-Vigdal, Amanda J.
    Stefanutti, Erin
    Schwarz, Margaret A.
    Monahan, Sheena
    Smith, Victoria
    Schwarz, Roderich E.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (06) : 3878 - 3887
  • [25] Towards improved predictability in pre-clinical research: Human 3D neuralin vitro model for assessment of gene therapy vectors
    Simao, D.
    Pinto, C.
    Fernandes, P.
    Piersanti, S.
    Saggio, I.
    Collinson, L. M.
    Schiavo, G.
    Kremer, E. J.
    Carrondo, M. J. T.
    Alves, P. M.
    Brito, C.
    HUMAN GENE THERAPY, 2015, 26 (10) : A83 - A83
  • [26] Towards improved predictability in pre-clinical research: Human dopaminergic 3D in vitro model for development of gene delivery strategies
    Simao, D.
    Pinto, C.
    Fernandes, P.
    Serra, M.
    Teixeira, A. P.
    Piersanti, S.
    Ibanes, S.
    Gennetier, A.
    Saggio, I.
    Collinson, L.
    Weston, A.
    Schiavo, G.
    Kremer, E. J.
    Alves, P. M.
    Brito, C.
    HUMAN GENE THERAPY, 2013, 24 (12) : A118 - A118
  • [27] The Revolutionary Roads to Study Cell-Cell Interactions in 3D In Vitro Pancreatic Cancer Models
    Delle Cave, Donatella
    Rizzo, Riccardo
    Sainz, Bruno, Jr.
    Gigli, Giuseppe
    del Mercato, Loretta L.
    Lonardo, Enza
    CANCERS, 2021, 13 (04) : 1 - 19
  • [28] Assessing Drug Efficacy in a Miniaturized Pancreatic Cancer In Vitro 3D Cell Culture Model
    Shelper, Todd B.
    Lovitt, Carrie J.
    Avery, Vicky M.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2016, 14 (07) : 367 - 380
  • [29] The development of in vitro organotypic 3D vulvar models to study tumor-stroma interaction and drug efficacy
    Wu, Shidi
    Huisman, Bertine W.
    Rietveld, Marion H.
    Rissmann, Robert
    Vermeer, Maarten H.
    Van Poelgeest, Mariette I. E.
    El Ghalbzouri, Abdoelwaheb
    CELLULAR ONCOLOGY, 2024, 47 (03) : 883 - 896
  • [30] 3D IN VITRO TUMOR MICROENVIRONMENT MODELS FOR SCREENING CAR-T CELL THERAPY EFFICACY
    Xue, Bin
    Vermond, Sophie
    Herbrand, Ulrike
    Harris, David
    Moiset, Gemma
    Hribar, Kolin
    Schuler, Julia
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A314 - A314